Company intelligence / Profile preview
Genetic
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
Overview
Genetic is an integrated Italian pharmaceutical company focused on the research, development, and manufacturing of specialized medicines, particularly in the respiratory, ophthalmic, and cardiovascular therapeutic areas. The company operates advanced manufacturing facilities that provide Contract Development and Manufacturing Organization (CDMO) services, specializing in sterile liquids and blow-fill-seal technology. Genetic's product portfolio includes a wide range of branded and generic treatments delivered via inhalers, nebulizers, and eye drops. With a strong emphasis on quality and innovation, the company serves both the domestic Italian market and international partners through licensing and supply agreements.
- Therapeutic areas
- OphthalmologyCardiovascularImmunologyPulmonology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Genetic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genetic.